Published in Gene Therapy Weekly, January 4th, 2007
Study 1: According to recently published research from the United States, human neural stem cells (NSCs) target experimental intracranial medulloblastoma and deliver a therapeutic gene leading to tumor regression.
"Based on studies of the extensive tropism of neural stem cells (NSC) toward malignant gliomas and the secretion of growth factors common to glioma...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.